medigraphic.com
ISSN 1816-8450 (Electronic)

2021, Number 1

<< Back Next >>

Geroinfo 2021; 16 (1)

Predisposing factors to COVID-19 and the benefits of nutrition in older adults

Mejía RB

Language: Spanish
References: 28
Page:
PDF size: 313.81 Kb.


ABSTRACT

Introduction: At the end of 2019, COVID 19 (coronavirus disease 2019) emerged, a new disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-Cov 2). The age group with the highest susceptibility to contracting the infection and its complications has been the elderly, with the highest rate of respiratory distress syndrome, water and mortality; this population has several factors that contribute to the increase in this vulnerability.
Objective: This review aims to compile the predisposing factors that contribute to COVID-19 and to determine the usefulness of dietary nutrients as a benefit for this disease in older people.
Methods: A bibliographic review of articles in Pubmed, Google Scholar and LILACS was carried out, using keywords related to the objectives. Articles related to publication date between 2020- 2021 were retrieved, using keywords such as: Covid 19, Sars-CoV2, older adult, clinical manifestations, diet, vitamin D, said search in Spanish and English.
Conclusion: The world is currently in a pandemic caused by SARS CoV-2, with a high rate of morbidity and mortality. The geriatric population has characteristic risk factors that make it more susceptible to contracting COVID 19. The nutritional status of older people is a key point for the evolution and treatment of COVID 19 to maintain an adequate immune response.


REFERENCES

  1. Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, et al. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules [Internet]. 2020 2020 [citado 26 Nov 2021];26(1):39. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795815/

  2. Grubaugh ND, Ladner JT, Lemey P, Pybus OG, Rambaut A, Holmes EC, et al. Tracking virus outbreaks in the twenty-first century. Nat Microbiol [Internet]. 2019 2020 [citado 26 Nov 2021];4(1):10-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345516/

  3. Smorenberg A, Peters EJ, van Daele PL, Nossent EJ, Muller M. How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity. Eur J Intern Med [Internet]. 2021 [citado 26 Nov 2021];83:1-5. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703548/

  4. Abreu MRP, Tejeda JJG, Guach RAD. Características clínico-epidemiológicas de la COVID-19. Revista Habanera de Ciencias Médicas [Internet]. 2020 [citado 26 Nov 2021];19(2):1-15. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=97798

  5. Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol [Internet]. 2020 [citado 26 Nov 2021];1-14. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537588/

  6. Giovanetti M, Benedetti F, Campisi G, Ciccozzi A, Fabris S, Ceccarelli G, et al. Evolution patterns of SARS-CoV-2: Snapshot on its genome variants. Biochem Biophys Res Commun [Internet]. 2021 [citado 6 Nov 2021];538:88-91. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836704/

  7. Salian VS, Wright JA, Vedell PT, Nair S, Li C, Kandimalla M, et al. COVID-19- Transmission, Current Treatment, and Future T(3):herapeutic Strategies. Mol Pharm [Internet]. 2021 [citado 26 Nov 2021]; 18(3):754-771. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839412/

  8. Anka AU, Tahir MI, Abubakar SD, Alsabbagh M, Zian Z, Hamedifar H, et al. Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management. Scand J Immunol [Internet]. 2020 [citado 28 Nov 21]; 93(4). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744910/

  9. Astorga G, Barrientos Calvo I. Infección por COVID-19 en población adulta mayor: recomendaciones para profesionales. [Internet]. 2020 [citado 16 de diciembre de 2021]; 85(629) 44-50. Disponible en: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2020/rmc20629i.pdf

  10. Grolli RE, Mingoti MED, Bertollo AG, Luzardo AR, Quevedo J, Réus GZ, et al. Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates. Mol Neurobiol [Internet]. 2021[citado 29 Nov 21];58 (5): 1905-1916. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744910/

  11. Falcón JCE, Almeida AC, Navarro LMM, Quintana MG. La COVID-19 y su impacto en la salud del adulto mayor. Archivos del Hospital Universitario «General Calixto García» [Internet]. 2020 [citado 16 de diciembre de 2021];8(3). Disponible en: http://www.revcalixto.sld.cu/index.php/ahcg/article/view/568

  12. Pallath MM, Ahirwar AK, Tripathi SC, Asia P, Sakarde A, Gopal N. COVID-19 and nutritional deficiency: a review of existing knowledge. Hormone Molecular Biology and Clinical Investigation [Internet]. 2021 [citado 05 Dic 21];42(1):77-85. Disponible en: COVID-19 and nutritional deficiency: a review of existing knowledge (degruyter.com)

  13. Yang Y-C, Chou C-L, Kao C-L. Exercise, nutrition, and medication considerations in the light of the COVID pandemic, with specific focus on geriatric population: A literature review. J Chin Med Assoc [Internet]. 2020[ citado 06 Dic 21];83(11):977-80. Disponible en: . https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434014/

  14. Verkhratsky A, Li Q, Melino S, Melino G, Shi Y. Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases? Biol Direct [Internet]. 2020 [citado 07 Dic 21];15 (1):28. 28. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691955/

  15. Abizanda Soler P, Rodríguez Mañas L. Tratado de Medicina Geriátrica. Fundamentos de la Atención Sanitaria a los Mayores. 2° ed. Barcelona, España: Elsevier; 2020. 1244 p.

  16. Piotrowicz K, Gąsowski J, Michel J-P, Veronese N. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res [Internet]. 2021 [citado 06 dic 21];33(10):2887-2898. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323089/

  17. Kumar P, Kumar M, Bedi O, Gupta M, Kumar S, Jaiswal G, et al. Role of vitamins and minerals as immunity boosters in COVID-19. Inflammopharmacology [Internet]. 2021[ ciatado 06 dic 21];29(4):1001-1016. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190991/

  18. Arruda de Souza Monnerat J, Ribeiro de Souza P, Monteiro da Fonseca Cardoso L, Dario Mattos J, de Souza Rocha G, Frauches Medeiros R. Micronutrients and bioactive compounds in the immunological pathways related to SARS-CoV-2 (adults and elderly). Eur J Nutr [Internet]. 2020 [citado 15 dic 21];60 (2):559-579. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576552/

  19. Shakoor H, Feehan J, Mikkelsen K, Al Dhaheri AS, Ali HI, Platat C, et al. Be well: A potential role for vitamin B in COVID-19. Maturitas [Internet]. 2021 [citado 16 dic 21]; 143: 1-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415215/

  20. Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) ]blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J Autoimmun [Internet]. 2020 [citado 16 dic 21];111:102452. doi: 10.1016/j.jaut.2020.102452

  21. Sheybani Z, Dokoohaki MH, Negahdaripour M, Dehdashti M, Zolghadr H, Moghadami M, et al. The Role of Folic Acid in the Management of Respiratory Disease Caused by COVID-19.[Internet]. 2020 [citado 23 de diciembre de 2021]. doi: 10.26434/chemrxiv.12034980.v1

  22. Wee AKH. COVID-19’s toll on the elderly and those with diabetes mellitus – Is vitamin B12 deficiency an accomplice? Med Hypotheses [Internet]. 2021[citado 23 dic 21];146:110374. doi: 10.1016/j.mehy.2020.110374

  23. Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY, et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition [Internet]. 2020 [citado 23 dic 21];79:111017. doi: 10.1016/j.nut.2020.111017

  24. Milani GP, Macchi M, Guz-Mark A. Vitamin C in the Treatment of COVID-19. Nutrients [Internet]. 2021[citado 23 dic 21];13(4):1172. doi: 10.3390/nu13041172

  25. Farid N, Rola N, Koch EAT, Nakhoul N. Active vitamin D supplementation and COVID-19 infections: review. Ir J Med Sci [Internet]. 2021 [citado 25 dic 21];190 (4): 1271-4. doi: 10.1007/s11845-020-02452-8. doi: 10.1007/s11845-020-02452-8

  26. Shakoor H, Feehan J, Al Dhaheri AS, Ali HI, Platat C, Ismail LC, et al. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas [Internet]. 21021 [citado 25 dic 21];143:1-9. doi: 10.1016/j.maturitas.2020.08.003

  27. de Almeida Brasiel PG. The key role of zinc in elderly immunity: A possible approach in the COVID-19 crisis. Clin Nutr ESPEN [Internet]. 2020 citado 25 dic 21];38:65-6. doi: 10.1016/j.clnesp.2020.06.003

  28. Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes Metab Syndr [Internet] 2020 citado 25-dic-21];14(4):367-82. doi: 10.1016/j.dsx.2020.04.015




2020     |     www.medigraphic.com